E-DRUG: eBMJ on antibiotic resistance

E-drug: eBMJ on antibiotic resistance

Dear E-druggers

Just alerting you that the BMJ of tomorrow (!) is already available
today in electronic format (for free), and this week has several
articles on antimicrobial resistance.

Visit http://www.bmj.com/cgi/collection/drugs:therapeutic

For those with no live Internet, you can use the GETWEB command:

Prepare an email message to the following address:
getweb@usa.healthnet.org

In the body of the text, type the following and leave a blank line
between the commands:

begin

GET http://www.bmj.com/cgi/collection/drugs:therapeutic

end

Now send the message.

You can retrieve several articles in the same message by
separating each GET command by a blank line, and an 'end' as last
line..

You can also subscribe at eBMJ to customized alerts (eg on drugs)
Info at: http://www.bmj.com/cgi/customalert

kind regards and happy surfing!

Wilbert Bannenberg
E-drug co-moderator

--------
eBMJ Customised @lerts: Selected Topics & Specialties

You have requested citations for the following eBMJ collections:

   * Drugs: Therapeutic
   * Health Systems and Services: Other Health Systems and Services
   * Public Health: Other Public Health

----------------------------------------------------
Drugs: Therapeutic
----------------------------------------------------
     http://www.bmj.com/cgi/collection/drugs:therapeutic

Antimicrobial resistance
     Richard Wise, Tony Hart, Otto Cars, Marc Streulens, Reinen Helmuth,
     Pentti Huovinen, and Marc Sprenger
     BMJ 1998;317 609-610

Antimicrobial resistance: a veterinary perspective
     Q A McKellar
     BMJ 1998;317 610-611

Antimicrobial resistance: bacteria on the defence
     Stuart B Levy
     BMJ 1998;317 612-613

Control of antimicrobial resistance: time for action
     Pentti Huovinen and Otto Cars
     BMJ 1998;317 613-614

Surveillance of antimicrobial resistance
     David M Livermore, Alasdair P Macgowan, and Martin C J Wale
     BMJ 1998;317 614-615

Lessons from New York's tuberculosis epidemic
     Richard Coker
     BMJ 1998;317 616-620

Facing the microbial threat
     BMJ 1998;317 620

Effect of preventive treatment for tuberculosis in adults infected with
HIV: systematic review of randomised placebo controlled trials
     David Wilkinson, S B Squire, and Paul Garner
     BMJ 1998;317 625-629

Are amoxycillin and folate inhibitors as effective as other antibiotics for
acute sinusitis? A meta-analysis
     Sarah D de Ferranti, John P A Ioannidis, Joseph Lau, William V
     Anninger, and Michael Barza
     BMJ 1998;317 632-637

Understanding the culture of prescribing: qualitative study of general
practitioners' and patients' perceptions of antibiotics for sore throats
     Christopher C Butler, Stephen Rollnick, Roisin Pill, Frances Maggs-
     Rapport, and Nigel Stott
     BMJ 1998;317 637-642

Science, medicine, and the future: The development of new antimicrobial
agents
     Richard Wise
     BMJ 1998;317 643-644

What can be done about resistance to antibiotics?
     John Turnidge
     BMJ 1998;317 645-647

Antimicrobial resistance in developing countries
     C A Hart and S Kariuki
     BMJ 1998;317 647-650

Surveillance of antimicrobial resistance---an international perspective
     R J Williams and M J Ryan
     BMJ 1998;317 651-660

The epidemiology of antimicrobial resistance in hospital acquired
infections: problems and possible solutions
     Marc J Struelens
     BMJ 1998;317 652-654

Community acquired infections and bacterial resistance
     Herman Goossens and Marc J W Sprenger
     BMJ 1998;317 654-657

The origins and molecular basis of antibiotic resistance
     Peter M Hawkey
     BMJ 1998;317 657-660

Antiviral drug resistance
     Deenan Pillay and Maria Zambon
     BMJ 1998;317 660-662

Regulating the use of antibiotics in the community
     Claude Carbon and Richard P Bax
     BMJ 1998;317 663-665

Use of antimicrobial drugs in veterinary practice
     A M Johnston
     BMJ 1998;317 665-667

Strategies for promoting judicious use of antibiotics by doctors and
patients
     Edward A Belongia and Benjamin Schwartz
     BMJ 1998;317 668-671

Community based approaches to the control of multidrug resistant
tuberculosis: introducing "DOTS-plus"
     Paul Farmer and Jim Yong Kim
     BMJ 1998;317 671-674

Vaccine delivery system using safe bacteria invented
     Abi Berger
     BMJ 1998;317 620

----------------------------------------------------
Health Systems and Services: Other Health Systems and Services
----------------------------------------------------
     http://www.bmj.com/cgi/collection/health_systems:other

Lessons from New York's tuberculosis epidemic
     Richard Coker
     BMJ 1998;317 616-620

Regulating the use of antibiotics in the community
     Claude Carbon and Richard P Bax
     BMJ 1998;317 663-665

Waiting lists respond to cash boost
     John Warden
     BMJ 1998;317 618

----------------------------------------------------
Public Health: Other Public Health
----------------------------------------------------
     http://www.bmj.com/cgi/collection/public_health:other

Surveillance of antimicrobial resistance
     David M Livermore, Alasdair P Macgowan, and Martin C J Wale
     BMJ 1998;317 614-615

Lessons from New York's tuberculosis epidemic
     Richard Coker
     BMJ 1998;317 616-620

Facing the microbial threat
     BMJ 1998;317 620

----------------------------------------------------

To unsubscribe from or edit your subscriptions to any eBMJ Customised
Alert, point your browser at http://www.bmj.com/cgi/customalert .

------------------------------------------------------------------------
Copyright (C) 1998 by the British Medical Journal.

Wilbert Bannenberg, SADAP Coordinator
Hallmark 938, P/Bag X 828, Pretoria 0001, South Africa
Tel work +27-12-3120374/5 Fax +27-12-3236745 Cellphone +27-82-5756249
Email bannew@hltrsa.pwv.gov.za (work)
Email WilbertBannenberg@compuserve.com (private)
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.